Literature DB >> 486539

Interactions between heparin and factor Xa. Inhibition of prothrombin activation.

F J Walker, C T Esmon.   

Abstract

The effects of heparin on prothrombin activation have been examined. Heparin was found to inhibit the rate of prothrombin activation by Factor Xa, calcium and phospholipid. In the absence of phospholipid, heparin had no effect on the rate of prothrombin activation. In contrast, heparin was found to increase the rate of activation of prethrombin-1 and prethrombin-2. Initial velocity studies indicated that heparin blocks lipid stimulation of prothrombin activation. In accord with this, binding studies demonstrated that heparin could displace Factor Xa, and in separate experiments, prothrombin, from phospholipid vesicles.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 486539     DOI: 10.1016/0304-4165(79)90085-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  The inhibition of thrombin-dependent positive-feedback reactions is critical to the expression of the anticoagulant effect of heparin.

Authors:  F A Ofosu; P Sie; G J Modi; F Fernandez; M R Buchanan; M A Blajchman; B Boneu; J Hirsh
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

2.  Activation of human protein C by blood coagulation factor Xa in the presence of anionic phospholipids. Enhancement by sulphated polysaccharides.

Authors:  J M Freyssinet; M L Wiesel; L Grunebaum; J M Pereillo; J Gauchy; S Schuhler; G Freund; J P Cazenave
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

3.  The effect of Ca2+, phospholipid and factor V on the anti-(factor Xa) activity of heparin and its high-affinity oligosaccharides.

Authors:  T W Barrowcliffe; S J Havercroft; G Kemball-Cook; U Lindahl
Journal:  Biochem J       Date:  1987-04-01       Impact factor: 3.857

4.  In vitro and in vivo characterization of a reversible synthetic heparin analog.

Authors:  Matthew F Whelihan; Brian Cooley; Yongmei Xu; Rafal Pawlinski; Jian Liu; Nigel S Key
Journal:  Thromb Res       Date:  2015-12-10       Impact factor: 3.944

Review 5.  Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins.

Authors:  M Verstraete
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.